Companies ›Healthcare ›AALR3.SA

AALR3.SA — B3 (São Paulo) Healthcare Facilities & Services

Allianca Saude e Participacoes SA

$3,35

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

9,2 %

ROE

-11,2 %

Net margin

-10,1 %

Debt / equity

0,87

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

Allianca Saude e Participacoes SA provides healthcare services and operates in the pharmaceuticals segment, generating revenue primarily through service provision and product sales.

Business. Allianca Saude e Participacoes SA (AALR3.SA) is a healthcare company operating in the Healthcare Facilities & Services industry. The firm is headquartered in Brazil and is primarily listed on the B3 (São Paulo) stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

-11,2 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning AALR3.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to AALR3.SA. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Allianca Saude e Participacoes SA (AALR3.SA) is a healthcare company operating in the Healthcare Facilities & Services industry. The firm is headquartered in Brazil and is primarily listed on the B3 (São Paulo) stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

AI synthesis

GENERATED

Allianca Saude e Participacoes SA has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.04, suggesting limited short-term liquidity cushion. The company's free cash flow is negative at -108.36 million BRL, and operating cash flow is also negative at -41.02 million BRL, signaling cash flow constraints.

The company's return on equity is -11.24%, and return on assets is -4.26%, both significantly below the industry norms for healthcare providers, indicating poor profitability and asset utilization. These metrics suggest the company is underperforming relative to its peers in generating returns for shareholders and managing its asset base effectively.

Allianca Saude e Participacoes SA's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases exposure to sector-specific and regional risks. The company's capital expenditures are -99.39 million BRL, indicating a reduction in investment in long-term assets.

The company's revenue growth is not disclosed, but the negative net income of -123.09 million BRL and declining cash flows suggest a challenging growth trajectory. The company's risk assessment indicates medium liquidity risk and low dilution risk, but the negative net cash position after subtracting total debt is a key flag.

Recent events and filings do not provide specific details on strategic initiatives or operational changes, but the company's financial performance and cash flow issues suggest a need for operational or strategic adjustments.

Key takeaways

Allianca Saude e Participacoes SA is experiencing negative returns on equity and assets, indicating poor profitability.
The company has a moderate debt-to-equity ratio but faces liquidity constraints with a current ratio of 1.04.
Revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
Free cash flow and operating cash flow are negative, signaling cash flow challenges.
The company's liquidity risk is medium, and dilution risk is low, but the negative net cash position is a concern.
"margin_outlook_rationale": "The company's negative return on equity and assets indicates declining profitability, driven by poor cost management and revenue generation.",

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

$3,35

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$1.09B

Net cashⓘ

-$857.2M

Current ratioⓘ

1.0

Debt / equityⓘ

0.9

ROAⓘ

-4.3%

ROEⓘ

-11.2%

Cash conversionⓘ

33.0%

CapEx / revenueⓘ

-8.2%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin9,2 %Above median

Net Margin-10,1 %Bottom quartile

ROE-11,2 %Bottom quartile

Capex / Rev-8,2 %Below median

D/E0,87Below median

Cash Conv0,33Below median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Allianca Saude e Participacoes SA Market data — financials · 2026-05-27

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

AALR3.SACanonical

B3 (São Paulo) · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread